Eisai Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.
The item "Operating-Expenses" stands at 575.36 Billion Japanese Yens for the trailing twelve months (TTM) period ending 09/30/2025.
Eisai Co. Ltd.'s second quarter result of 140.60 Billion JPY for the item "Operating Expenses" represents an increase of 0.93 percent compared to it's first quarter result.
Also, Eisai Co. Ltd.'s second quarter result of 140.60 Billion JPY for the item "Operating Expenses" represents a decrease of -1.58 percent compared to it's second quarter result of last year.
Looking again at the trailing twelve months series (TTM), Eisai Co. Ltd.'s second quarter result of 575.36 Billion JPY for the item "Operating Expenses" represents a decrease of -0.39 percent compared to it's first quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 4.62 percent compared to the value the year prior.
The 1 year change in percent is 4.62.
The 3 year change in percent is 1.49.
The 5 year change in percent is 39.11.
The 10 year change in percent is 75.82.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Operating Expenses | 905,699,262,464.00 |
![]() | Johnson & Johnson - Operating Expenses | 486,508,953,600.00 |
![]() | AbbVie Inc - Operating Expenses | 399,570,305,024.00 |
![]() | Roche Holding AG - Operating Expenses | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Operating Expenses | 280,205,508,085.11 |